1-7 of 7
David Steensma
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Canakinumab Effects on Erythropoiesis, Cardiovascular Risk, and Clonal Hematopoiesis: Proteogenomic Analysis of the Cantos Randomized Clinical Trial

Janghee Woo, Darlene Lu, Andrew Lewandowski, Paul M. Ridker, Benjamin L. Ebert, David Steensma
Journal: Blood
Blood (2022) 140 (Supplement 1): 2236–2237.
https://doi.org/10.1182/blood-2022-167275
Published: 2022
Journal Articles

Efficacy and Safety of Ruxolitinib for Treatment of Symptomatic Chronic Myelomonocytic Leukemia (CMML): Results of a Multicenter Phase II Clinical Trial

Eric Padron, Sara M Tinsley-Vance, Amy E. DeZern, Hetty E. Carraway, Marlise R. Luskin, Gail J. Roboz, Onyee Chan, Meagan Horton, Aaron T. Gerds, David A. Sallman, Andrew Kuykendall, David Steensma, Maria E Balasis, Jeffrey E. Lancet, Mikkael A. Sekeres, Rami S. Komrokji
Journal: Blood
Blood (2022) 140 (Supplement 1): 1101–1103.
https://doi.org/10.1182/blood-2022-170144
Published: 2022
Journal Articles

A Novel Antibody-Drug Conjugate Targeting CCR7 in Hematologic Malignancies

Anhthu Dang, Deborah Knee, Cui Ying Wang, Feng Gao, Guoxun Liu, Sergio Briones, Michelle Coulson, Jessica Makofske, Keith Mansfield, May Liu, Tanya Mulvey, Emily K Meseck, Steve Woolfenden, Sean G Buchanan, David Steensma, Vasileios Askoxylakis
Journal: Blood
Blood (2022) 140 (Supplement 1): 11564–11565.
https://doi.org/10.1182/blood-2022-159910
Published: 2022
Journal Articles

Prospective Cohort Study of Geriatric Assessment in Older Patients with Acute Myeloid Leukemia

Gabriela Motyckova, MD, PhD, Alexander E. Sherman, MS, K. Rebecca Fega, PhD, Daniel J. DeAngelo, MD, PhD, Gregory A. Abel, MD, MPH, David Steensma, MD, Martha Wadleigh, MD, Richard M. Stone, MD, Jane A. Driver, MD
Journal: Blood
Blood (2012) 120 (21): 4285.
https://doi.org/10.1182/blood.V120.21.4285.4285
Published: 2012
Journal Articles

Geriatric Assessment Variables Add Prognostic Value to the International Prognostic Scoring System

Gabriela Motyckova, MD, PhD, K Rebecca Fega, PhD, Alexander E. Sherman, MS, Daniel J. DeAngelo, MD, PhD, Gregory A. Abel, MD, MPH, David Steensma, MD, Martha Wadleigh, MD, Richard M. Stone, MD, Jane A. Driver, MD
Journal: Blood
Blood (2012) 120 (21): 4933.
https://doi.org/10.1182/blood.V120.21.4933.4933
Published: 2012
Journal Articles

Iron Chelation with Deferasirox (Exjade ® ) Improves Iron Burden in Patients with Myelodysplastic Syndromes (MDS)

Alan F List, Maria R Baer, David Steensma, Azra Raza, Jason Esposito, Jodi Virkus, Carole Paley, John Feigert, Emmanuel C Besa
Journal: Blood
Blood (2008) 112 (11): 634.
https://doi.org/10.1182/blood.V112.11.634.634
Published: 2008
Journal Articles

Iron Parameters in 84 MDS Patients Enrolled in a Deferasirox (Exjade®, ICL670) Multicenter Trial.

Alan F. List, Jason Esposito, Jodie Decker, Maria R. Baer, Bayard Powell, David Steensma, Azra Raza, Howard Terebelo, Jaroslaw Maciejewski, Stuart L. Goldberg, Carole Paley
Journal: Blood
Blood (2006) 108 (11): 4847.
https://doi.org/10.1182/blood.V108.11.4847.4847
Published: 2006